The Perioperative Use of Levosimendan as a Means of Optimizing the Surgical Outcome in Patients with Severe Heart Insufficiency Undergoing Cardiac Surgery

被引:2
|
作者
Leivaditis, Vasileios [1 ]
Grapatsas, Konstantinos [2 ]
Papaporfyriou, Anastasia [3 ]
Galanis, Michail [4 ]
Koletsis, Efstratios [5 ]
Charokopos, Nikolaos [5 ]
Haussmann, Erich [1 ]
Kaplunov, Vladislav [1 ]
Papatriantafyllou, Athanasios [6 ]
Dahm, Manfred [1 ]
机构
[1] Westpfalz Klinikum, Dept Cardiothorac & Vasc Surg, D-67655 Kaiserslautern, Germany
[2] Univ Duisburg Essen, Univ Hosp Essen, West German Lung Ctr, Dept Thorac Surg & Thorac Endoscopy,Ruhrlandklin, D-45239 Essen, Germany
[3] Vienna Univ Hosp, Dept Pulmonol, Internal Med 2, A-1090 Vienna, Austria
[4] Univ Bern, Bern Univ Hosp, Inselspital, Dept Thorac Surg, CH-3012 Bern, Switzerland
[5] Univ Hosp Patras, Dept Cardiothorac Surg, Patras 26504, Greece
[6] Gen Hosp Patras Agios Andreas, Dept Gen Surg, Patras 26332, Greece
关键词
levosimendan; heart failure; cardiac surgery; myocardial injury; angina pectoris; LEFT-VENTRICULAR DYSFUNCTION; ATRIAL-FIBRILLATION; LUNG INJURY; METAANALYSIS; MORTALITY; TERM;
D O I
10.3390/jcdd10080332
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Postoperative myocardial dysfunction following cardiac surgery is a relatively common occurrence. Levosimendan, a calcium sensitizer and inotropic drug, has shown potential in improving outcomes for patients with low preoperative ejection fraction (EF) and myocardial dysfunction after cardiac surgery. This study aims to evaluate the efficacy of levosimendan in optimizing the surgical outcome for such patients. Methods: A retrospective analysis was conducted on 314 patients with preoperative severe heart failure who underwent cardiac surgery. Among them, 184 patients received perioperative adjunctive therapy with levosimendan, while a comparable group of 130 patients received conventional treatment. Results: The use of levosimendan demonstrated several advantages in postoperative outcomes. It significantly improved short- and long-term survival rates after cardiac surgery, enhanced hemodynamic stability, reduced the requirement for inotropic support, and facilitated faster weaning from ventilator support. Patients who received levosimendan reported reduced angina and dyspnea symptoms, as well as fewer postoperative arrhythmias. Furthermore, levosimendan helped minimize myocardial injury inevitable after cardiac surgery. The levosimendan group also exhibited a notable reduction in hospital readmissions. Conclusions: This study provides evidence of several benefits associated with the perioperative use of levosimendan. However, further prospective randomized studies are warranted to standardize and comprehensively document the other perioperative therapies, in order to validate these findings and establish stronger conclusions.
引用
收藏
页数:18
相关论文
共 50 条
  • [21] Timing of Perioperative Methylprednisolone and Outcome in Infants Undergoing Heart Surgery
    Pasquali, Sara K.
    Jacobs, Jeffrey P.
    He, Xia
    Jacobs, Marshall L.
    O'Brien, Sean M.
    Hall, Matthew
    Jaquiss, Robert D.
    Welke, Karl F.
    Peterson, Eric D.
    Shah, Samir S.
    Gaynor, J. W.
    Li, Jennifer S.
    CIRCULATION, 2011, 124 (21)
  • [22] Perioperative myocardial damage and cardiac outcome in patients-at-risk undergoing non-cardiac surgery
    Tibblin, A. O.
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2010, 54 (05) : 656 - 657
  • [23] Perioperative Management of Valvular Heart Disease in Patients Undergoing Non-Cardiac Surgery
    Jalali, Yashar
    Jalali, Monika
    Stevlik, Jan
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (11)
  • [24] Perioperative Considerations of Novel Antidiabetic Agents in Heart Failure Patients Undergoing Cardiac Surgery
    Wang, Ashley
    Bitzas, Savannah
    Perez, Dilsa
    Schwartz, Jonathon
    Zaidi, Saleem
    Oster, Jonathan
    Bergese, Sergio D.
    LIFE-BASEL, 2025, 15 (03):
  • [25] Perioperative metabolic changes in patients undergoing cardiac surgery
    Jakob, Stephan M.
    Stanga, Zeno
    NUTRITION, 2010, 26 (04) : 349 - 353
  • [26] Thrombocytopenia: Perioperative Considerations for Patients Undergoing Cardiac Surgery
    Klompas, Allan M.
    Boswell, Michael R.
    Plack, Daniel L.
    Smith, Mark M.
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2022, 36 (03) : 893 - 905
  • [27] Optimizing Perioperative Renal Replacement Therapy for Patients Undergoing Cardiac Surgical Procedures Requiring Cardiopulmonary Bypass
    Stevens, Jacob S.
    Hastie, Jonathan M.
    Spellman, Jessica
    Mittel, Aaron
    Beck, James
    Mullin, Dana A.
    Fung, Kenmond
    Argenziano, Michael
    Takayama, Hiroo
    Radhakrishnan, Jai
    BLOOD PURIFICATION, 2023, 51 : 3 - 9
  • [28] Thrombocytosis: Perioperative Considerations for Patients Undergoing Cardiac Surgery
    Smith, Bradford B.
    Boswell, Michael R.
    Matzek, Luke J.
    Smith, Mark M.
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2020, 34 (03) : 772 - 781
  • [29] Use of perioperative nesiritide improves clinical outcomes and decreases resource utilization in heart failure patients undergoing cardiac surgery
    Russo, Mark J.
    Hobbs, Robert E.
    Moazami, Nader
    Burton, Nelson
    Copeland, Jack
    Oz, Mehmet C.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 301A - 302A
  • [30] OPEN-HEART SURGERY IN PATIENTS WITH SEVERE RENAL-INSUFFICIENCY AND THOSE UNDERGOING DIALYSIS
    PAVIE, A
    MUSSAT, J
    VALLEE, D
    ROTTEMBOURG, J
    BARTHELEMY, A
    GANDJBAKHCH, I
    CABROL, C
    ANNALES DE CARDIOLOGIE ET D ANGEIOLOGIE, 1984, 33 (01): : 56 - 56